FundedIQ
Biotechnology

CoreMap: Funding, Investors & Team (Sep 2026)

CoreMap exists to improve patient outcomes by delivering advanced diagnostic technology to electrophysiologists and patients.

coremapmedical.com LinkedIn Burlington, United States 11-50 employees Founded 2016
Total raised
$67.5M
Rounds
3
Latest
Series C
Jul 2026

CoreMap has raised $67.5M across 3 funding rounds on record, the most recent a Series C of $37.0M announced in Jul 2026.

That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

CoreMap Company Profile and Key Stats

Total funding raised
$67.5M
across 3 rounds on record
Funding rounds on record
3
Latest funding round
Series C
$37.0M in Jul 2026
Employees
11-50
reported band
Founded
2016
Headquarters
Burlington, United States
Investors on record
6
5 named below

Latest funding round on record: Jul 2026.

CoreMap Funding Rounds

Date
Round
Amount
Series C
$37.0M
Series B
$20.0M
Undisclosed round
$10.5M

CoreMap raised $10.5M in an undisclosed round announced in Sep 2020.

1.4 years later, a Series B of $20.0M was announced in Feb 2022.

4.4 years later, a Series C of $37.0M was announced in Jul 2026.

CoreMap Investors

National Science Foundation Medtronic Minnow Ventures Qure Ventures Russ Scully

6 investors are recorded in total; the 5 named above are those the record identifies.

CoreMap Founders and Leadership Team

Name
Role
Contact
Selin D
Founder
Locked
Sarah Kalil
CEO
Locked
Steven Berlin
CEO
Locked

Contact details for the CoreMap team: 3 of 3 have an email address on file, 2 have a LinkedIn profile.

Start 14-day free trial →

CoreMap Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,183
$8.0M
29,981
$7.5M
1,848
$60M

CoreMap's latest round of $37.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like CoreMap in Biotechnology and Burlington

Companies Similar to CoreMap

Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…

Series E $92.5M

Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…

Series B $40.0M

Datavant is a developer of a healthcare data platform dedicated to assisting in protecting, matching, and…

Private Equity

Shennon Biotechnologies conducts a thorough examination and control of an enormous quantity of cells,…

Undisclosed round $12.0M

SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory…

Undisclosed round $960k

DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer…

Series B $4.0M

Solstice Oncology is a clinical stage immuno-oncology company

Series A $225M

Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad…

Series F $275M

BrainChild Bio is a biotechnology company in the clinical stage that specializes in pediatric brain tumors.…

Series A $116M

Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…

Series B $65.5M

Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…

Seed $7.0M

ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…

Series C $10.0M

CoreMap Funding FAQs

What does CoreMap do?

CoreMap exists to improve patient outcomes by delivering advanced diagnostic technology to electrophysiologists and patients.

How much funding has CoreMap raised?

CoreMap has raised $67.5M across 3 rounds on record. The most recent is a Series C of $37.0M announced in Jul 2026.

When did CoreMap last raise funding?

CoreMap's most recent funding round on record is a Series C of $37.0M, announced in Jul 2026.

Who has invested in CoreMap?

Investors on record for CoreMap include National Science Foundation, Medtronic, Minnow Ventures, Qure Ventures, Russ Scully. FundedIQ records 6 investors in total.

Who founded CoreMap?

FundedIQ lists Selin D (Founder) at CoreMap.

Who is the CEO of CoreMap?

Sarah Kalil is listed as CEO at CoreMap.

Where is CoreMap headquartered?

CoreMap is based in Burlington, Massachusetts, United States.

How many employees does CoreMap have?

CoreMap is in the 11-50 employee band.

When was CoreMap founded?

CoreMap was founded in 2016.

How does CoreMap's funding compare to other Biotechnology startups?

CoreMap's latest round of $37.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.

About FundedIQ's CoreMap Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for CoreMap is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.